Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Oral Amoxicillin in Comparison to Intravenous Ceftriaxone in Treatment of Uncomplicated Community Acquired Pneumonia (Cap) Among Children of Age 2-5 Years of Age

NCT06532409 is registered in ClinicalTrials.gov with RESnTEC, Institute of Research as lead sponsor.

NCT NCT06532409
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06532409 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Oral Amoxicillin in Comparison to Intravenous Ceftriaxone in Treatment of Uncomplicated Community Acquired Pneumonia (Cap) Among Children of Age 2-5 Years of Age
Lead sponsor
RESnTEC, Institute of Research
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2024
Completion date
September 30, 2025
Enrollment
114 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

community-acquired pneumonia